Taco van Tiel is Head of the U.S., accountable for delivering on our Patient Impact ambitions in the U.S. In this role, he seeks to forge strong connections with patients, caregivers, healthcare professionals, and other stakeholders that enable the UCB teams to generate the greatest impact for the patients we serve.

Taco is a strong believer in the power of human capital to drive success for our multiple stakeholders. He has had an extensive career leading and growing teams that are empowered to maximize value for patients, multiple stakeholders, and society at large. He stimulates teams to bring together the expertise, talent, tools, and the curiosity needed to pursue the right solutions for those who live with severe diseases.

Prior to leading the U.S. market, Taco led the UCB Insights to Impact Go-To-Market (G2M) organization at UCB. With a global scope, he oversaw all Commercial Financial Operations as well as all Insights Functions within UCB, including Advanced Analytics.

Since joining UCB in March of 2008, Taco has held leadership roles as Head of UCB Operations in Japan, China & International Markets, working with those teams to ensure patients in those markets gained appropriate access to UCB’s solutions. He also previously served as axSpA Mission Head, where he facilitated the U.S. launch of CIMZIA for nr-axSpA, leading the in-depth understanding of patient needs and their environments for the development and commercialization of solutions that create sustainable and meaningful value for people living with axSpA.

Other previous positions include Head of Neurology in Japan, Franchise General Manager of Neurology in the UK, and Director of New Product Planning in Brussels, Belgium.

Before joining UCB, Taco held various roles in sales, marketing, and general management across markets in Europe, Asia, and the USA. Taco received a Master of Science degree in economics from the VU University in Amsterdam, the Netherlands.

Download Bio.